COMPASS Pathways plc Stock Holdings Reduced by PFM Health Sciences LP
| CMPS Stock | USD 4.75 0.30 6.74% |
Slightly above 55% of Compass Pathways' private investors are presently thinking to get in. The analysis of overall sentiment of trading Compass Pathways Plc stock suggests that some investors are interested at this time. Compass Pathways' investing sentiment can be driven by a variety of factors including economic data, Compass Pathways' earnings reports, geopolitical events, and overall market trends.
Compass |
PFM Health Sciences LP cut its position in shares of COMPASS Pathways plc by 58.6 percent in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 451,267 shares of the companys stock after selling 638,325 shares during the period. PFM
Read at thelincolnianonline.com
 |
Compass Pathways Fundamental Analysis
We analyze Compass Pathways' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compass Pathways using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compass Pathways based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Compass Pathways is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Compass Pathways Plc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Compass Pathways stock to make a market-neutral strategy. Peer analysis of Compass Pathways could also be used in its relative valuation, which is a method of valuing Compass Pathways by comparing valuation metrics with similar companies.
Peers
Compass Pathways Related Equities
| ACHC | Acadia Healthcare | 1.20 | ||||
| ADUS | Addus HomeCare | 0.89 | ||||
| AMED | Amedisys | 0.56 | ||||
| FSNUY | Fresenius | 0.46 | ||||
| USPH | US Physicalrapy | 0.39 | ||||
| CCRN | Cross Country | 0.11 | ||||
| DVA | DaVita HealthCare | 0.84 | ||||
| EHAB | Enhabit | 1.27 | ||||
| AGL | Agilon Health | 1.44 | ||||
| ENSG | Ensign | 1.84 | ||||
| SGRY | Surgery Partners | 2.61 | ||||
| NHC | National HealthCare | 3.27 | ||||
| PNTG | Pennant | 4.07 | ||||
| INNV | InnovAge Holding | 4.27 |
Additional Tools for Compass Stock Analysis
When running Compass Pathways' price analysis, check to measure Compass Pathways' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Pathways is operating at the current time. Most of Compass Pathways' value examination focuses on studying past and present price action to predict the probability of Compass Pathways' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Pathways' price. Additionally, you may evaluate how the addition of Compass Pathways to your portfolios can decrease your overall portfolio volatility.